PRESS RELEASE published on 10/31/2025 at 18:52, 3 months 10 days ago Informations privilégiées / Autres communiqués Nomination de Yves Decadt en tant que membre du Conseil d'administration de Poxel renforce la structuration stratégique et commerciale de la société biopharmaceutique au stade clinique. Double expertise scientifique et stratégique apportée par Yves Decadt Conseil D'administration Biopharmaceutique Traitement Poxel Yves Decadt
BRIEF published on 10/16/2025 at 17:56, 3 months 25 days ago Poxel: 2024 financial results and receivership proceedings Financial Results Treasury TWYMEEG® Poxel Judicial Recovery
BRIEF published on 10/16/2025 at 17:56, 3 months 25 days ago Poxel : Résultats financiers 2024 et procédure de redressement judiciaire Résultats Financiers Trésorerie Redressement Judiciaire TWYMEEG® Poxel
PRESS RELEASE published on 10/16/2025 at 17:51, 3 months 25 days ago Inside Information / News release on accounts, results Poxel reports financial results for full year 2024, including positive net royalties and governance changes. Updates on operational and financial status provided. Commercial momentum for TWYMEEG® in Japan. Cash position and financing details shared Financial Results Cash Position Governance Changes TWYMEEG® Poxel
PRESS RELEASE published on 10/16/2025 at 17:51, 3 months 25 days ago Informations privilégiées / Communiqué sur comptes, résultats Poxel annonce ses résultats financiers 2024 avec des redevances positives pour TWYMEEG® et une procédure de redressement judiciaire en cours, plans de continuité et perspectives de ventes au Japon Résultats Financiers Redressement Judiciaire Poxel Redevances Ventes Japon
BRIEF published on 08/08/2025 at 17:50, 6 months 2 days ago POXEL Begins Judicial Reorganization Proceedings Metabolic Diseases Euronext Listing Judicial Recovery Steatohepatitis Observation Period
BRIEF published on 08/08/2025 at 17:50, 6 months 2 days ago POXEL Entame une Procédure de Redressement Judiciaire Maladies Métaboliques Redressement Judiciaire Cotation Euronext Période D'observation Stéatohépatite
PRESS RELEASE published on 08/08/2025 at 17:45, 6 months 2 days ago Informations privilégiées / Autres communiqués POXEL annonce l'ouverture d'une procédure de redressement judiciaire avec reprise de cotation de l'action le 11 août 2025. La société biopharmaceutique explore ses options pour poursuivre ses activités Biopharmaceutique Cotation Redressement Judiciaire Procédure Poxel
BRIEF published on 07/29/2025 at 20:21, 6 months 11 days ago Poxel Initiates Reorganization Amid Financial Struggles Creditors Reorganization Insolvency Corporate Changes Poxel
BRIEF published on 07/29/2025 at 20:21, 6 months 11 days ago Poxel entame une réorganisation en raison de difficultés financières Créanciers Reorganisation Insolvabilité Poxel Changements D'entreprise
Published on 02/10/2026 at 15:30, 4 hours 29 minutes ago Predictiv AI Establishes Asia Regional Office to Support Expansion Across Asia, Africa, and the Middle East
Published on 02/10/2026 at 15:00, 4 hours 59 minutes ago Haven Safety AI Launches AI-Native Safety Intelligence Platform Co-Founded with The AES Corporation and AI Fund
Published on 02/10/2026 at 14:30, 5 hours 29 minutes ago Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Published on 02/10/2026 at 14:00, 5 hours 59 minutes ago Horizon Aircraft Partners with North Aircraft Industries to Manufacture the Wings for the Cavorite X7
Published on 02/10/2026 at 19:07, 52 minutes ago Wacker Neuson Group publishes preliminary financial year 2025 figures and shows a positive outlook
Published on 02/10/2026 at 19:06, 52 minutes ago EQS-Adhoc: Wacker Neuson Group publishes preliminary financial year 2025 figures
Published on 02/10/2026 at 19:05, 53 minutes ago Quantifind Can Unlock Up to $177.9M in Annual Compliance Efficiency for Tier 1 Banks According to Celent Report
Published on 02/10/2026 at 18:52, 1 hour 6 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/10/2026 at 18:01, 1 hour 58 minutes ago EuroTeleSites Fulfills 2025 Guidance: Revenue Grows and Rises to 280.2 mEUR; Deleveraging Down to 5.5x
Published on 02/10/2026 at 18:24, 1 hour 34 minutes ago Mersen: Number of shares and voting rights as of January 31, 2026
Published on 02/10/2026 at 18:24, 1 hour 34 minutes ago Mersen : nombre d'actions et de droits de vote au 31 janvier 2026
Published on 02/10/2026 at 18:00, 1 hour 59 minutes ago CIS remporte plusieurs contrats stratégiques en Afrique, en Amérique du Sud et en Asie
Published on 02/10/2026 at 18:00, 1 hour 59 minutes ago CIS wins several strategic contracts in Africa, South America and Asia